Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mantel Cell Lymphoma Efficacy of Rituximab Maintenance

This study has been completed.
Sponsor:
Collaborator:
Lymphoma Study Association
Information provided by (Responsible Party):
French Innovative Leukemia Organisation
ClinicalTrials.gov Identifier:
NCT00921414
First received: May 27, 2009
Last updated: March 15, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)